522556 Material Tracking in a Fully Continuous Drug Substance Process

Carla Luciani1, Stephen B. Jeffery2, Jon Dieringer3, Robert Manson4, Edmond Kennedy5, Aoife Corrigan5, Martin Johnson6 and Scott A. May6, (1)Eli Lilly and Company, Indianapolis, IN, (2)Process Engineering, Eli Lilly and Company, Kinsale, Ireland, (3)SMDD, Eli Lilly & Co, Indianapolis, IN, (4)Kenny-Whelan Associates Ltd, Kinsale, Ireland, (5)Eli Lilly & Co, Kinsale, Ireland, (6)Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN
See more of this Session: Continuous Processing Technologies Applied in Drug Substance Manufacturing I
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum